Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk?

Panagiotis Anagnostis1, Vasilios G Athyros, Fotini Adamidou

  • 1Endocrinology Clinic, Hippokration Hospital, Thessaloniki, Greece. anagnwstis.pan@yahoo.gr

Insights

Vitamin D deficiency is linked to cardiovascular disease (CVD) risk. This review examines vitamin D

Area of Science:

  • Endocrinology
  • Cardiology
  • Nutritional Science

Background:

  • Vitamin D deficiency is a known cause of bone disease.
  • Emerging evidence suggests vitamin D influences numerous human physiological functions.
  • Epidemiological studies link vitamin D deficiency to increased cardiovascular disease (CVD) prevalence.

Purpose of the Study:

  • To review current data on the role of vitamin D deficiency in CVD development.
  • To analyze the impact of vitamin D supplementation on cardiovascular outcomes.

Main Methods:

  • Literature review of epidemiological studies.
  • Analysis of research on vitamin D's role in cardiometabolic risk factors.
  • Examination of studies on vitamin D supplementation and CVD.

Main Results:

  • Vitamin D deficiency is associated with hypertension, diabetes, dyslipidemia, and metabolic syndrome.
  • Vitamin D deficiency is implicated in the progression of atherosclerosis.
  • Data on the effect of vitamin D supplementation on cardiovascular outcomes are under review.

Conclusions:

  • Vitamin D deficiency is a significant factor in cardiovascular disease development.
  • Further research is needed to clarify the benefits of vitamin D supplementation for cardiovascular health.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...